scholarly article | Q13442814 |
P356 | DOI | 10.1093/NDT/15.1.71 |
P698 | PubMed publication ID | 10607770 |
P50 | author | Georg Martin Fiedler | Q42789231 |
P2093 | author name string | G A Müller | |
R W Grunewald | |||
B Stock | |||
J M Grunewald | |||
P2860 | cites work | Soluble CD8 in patients with rheumatic diseases | Q68343548 |
Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function | Q69096830 | ||
A critical analysis of serum and urine interleukin-2 receptor assays in renal allograft recipients | Q69798481 | ||
Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus | Q70757241 | ||
Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis | Q70766600 | ||
Soluble T lymphocyte markers in the diagnosis of cellular rejection and cytomegalovirus hepatitis in liver transplant recipients | Q72116227 | ||
Renal transplantation | Q72442105 | ||
A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individuals | Q72712217 | ||
High serum levels of soluble CD8 in insulin-dependent diabetes | Q72769505 | ||
Analysis of fine-needle aspiration biopsies by flow cytometry in kidney transplant patients | Q73536022 | ||
Monitoring of cytomegalovirus infections by the CD8+CD38+ T-cell subset in kidney transplant recipients | Q74150594 | ||
A secreted form of the human lymphocyte cell surface molecule CD8 arises from alternative splicing | Q24626062 | ||
Expression of different CD8 isoforms on distinct human lymphocyte subpopulations | Q28270908 | ||
Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients | Q33477067 | ||
Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen | Q34685578 | ||
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors | Q36230900 | ||
Immunochemical analysis of the released Leu-2 (T8) molecule | Q36349271 | ||
CD4+ but not CD8+ cells are essential for allorejection | Q36367566 | ||
Mechanisms of T lymphocyte activation | Q37377443 | ||
Interleukin-2: inception, impact, and implications | Q39603037 | ||
Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis | Q40691123 | ||
Serum soluble CD4 and CD8 levels in Kawasaki disease | Q40743998 | ||
The renal allograft biopsy | Q41168688 | ||
Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy | Q41184484 | ||
Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies | Q41503059 | ||
Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis | Q48712695 | ||
Soluble CD4: a Link Between Specific Immune Mechanisms and Non-Specific Inflammatory Responses? | Q58861603 | ||
Do CD4 or CD8 molecules provide a regulatory signal in T-cell activation? | Q67256818 | ||
Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis | Q67989733 | ||
Renal allograft rejection in CD4+ T cell-reconstituted athymic nude rats. The origin of CD4+ and CD8+ graft-infiltrating cells | Q68163558 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 71-77 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
P1476 | title | Soluble CD-4 and CD-8 as markers of immunological activation in renal transplant recipients | |
P478 | volume | 15 |
Q64965233 | Circulating CD3+HLA-DR+ Extracellular Vesicles as a Marker for Th1/Tc1-Type Immune Responses. |
Q37541921 | Clinical Significance of the Pharmacological Efficacy of Tacrolimus Estimated by the Lymphocyte Immunosuppressant Sensitivity Test (LIST) Before and After Renal Transplantation |
Q44650819 | Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding |
Search more.